Kazia Therapeutics appoints Sudha Rao as chief scientific officer
April 16, 2026 | 10:31
The Australian oncology drug developer named Rao to lead research and development for its cancer therapy pipeline.
Kazia Therapeutics reports immune complete response in TNBC
November 19, 2025 | 14:28
Kazia Therapeutics has announced an initial immune complete response in metastatic triple negative breast cancer alongside its Q4 update.
Latest News
Mobile Version